
Rationalist-adjacent musings on psychiatry
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 49 | Founded | 3 years ago | Last Issue | 4 days ago |
| Active | |||||

Hundreds of pages of FDA documents show major discrepancies between the FDA’s analysis of the ASCEND trial and the AJP publication. I try to correct the record.
I have a new Letter in the American Journal of Psychiatry about the clinical t...
A straight-forward way to improve the treatment of depression in primary care settings
I’ll admit that I’m a bit rigid and obsessive. So, it will come as no surprise that I have a few many frustrations with how we practice psychiatry, part...
This piece comes from several months reading TMS clinic websites. My critique is not of TMS, but of marketing that has gone too far. While I would prefer to write about clinical trials, I am convinced that this issue requires greater attent...
Using antipsychotics well is a tricky business. We certainly know that they work, but questions beyond that linger. Is the response that we see within the first handful of days of starting an antipsychotic because of improvements in psychot...
This is the first in a series of essays on two major concerns I have with the growing use of transcranial magnetic stimulation (TMS) for depression. The first concern is with TMS research. The second concern is the marketing of TMS. I think...
Subscribers, engagement, traffic and sponsorship for Polypharmacy.
| Subscribers | Engagement | 77 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Where Polypharmacy ranks on Google, and how much search traffic it brings in.
| Ranked Keywords | 35 | Monthly Search Traffic | Top Keywords |
|---|
How this newsletter ranks in the official Substack charts.
| #247 |
The writers behind this newsletter.
Psychiatrist, independently minded to a troublesome degree. Occasionally produces original thoughts worth sharing.
Psychiatrist focused on improving the quality of evidence in psychiatry. I’m pro-humility and against hype and bad science. All views my own.
You can find recent issues that have been published by Polypharmacy on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Polypharmacy, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Polypharmacy as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Polypharmacy using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Polypharmacy. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.